The Journal of family practice
-
Randomized Controlled Trial
Does concurrent use of clopidogrel and PPIs increase CV risk in patients with ACS?
No. Adding a proton pump inhibitor (PPI) in patients taking antiplatelet medications such as clopidogrel for acute coronary syndrome (ACS) doesn't increase the composite risk of cardiovascular (CV) events: CV death, myocardial infarction (MI), and cerebrovascular accident (CVA) (strength of recommendation: B, randomized, controlled trial [RCT] and prepon-derance of posthoc analyses of large RCTs).
-
► Foot pain ► "Purple" toe ► History of smoking.
-
Enlisting patients to self-collect specimens for human papillomavirus testing is an effective way to detect cervical precancer in those who might not otherwise undergo cervical cancer screening.
-
Was a drug or a comorbidity to blame for this patient's hyperpigmentation?
-
This review-with tables summarizing opioid options, dosing considerations, and recommendations for tapering-will help you provide rigorous Tx for noncancer pain while ensuring patient safety.